{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:12:31Z","timestamp":1788480751054,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100023181","name":"Agencja Bada\u0144 Medycznych","doi-asserted-by":"publisher","award":["2023\/ABM\/03\/000024"],"award-info":[{"award-number":["2023\/ABM\/03\/000024"]}],"id":[{"id":"10.13039\/501100023181","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55028-4","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:04:17Z","timestamp":1781730257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cardiovascular peptide markers are associated with age-related macular degeneration in the Bialystok PLUS general population cohort"],"prefix":"10.1038","volume":"16","author":[{"given":"Agnieszka","family":"Budnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Tuchli\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Lisowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Michnowska-Kobyli\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Anna","family":"Dmuchowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Chlabicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szpakowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlena","family":"Dubat\u00f3wka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Kondraciuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karol","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Konopi\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"55028_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/j.mcna.2021.01.003","volume":"105","author":"CJ Thomas","year":"2021","unstructured":"Thomas, C. J., Mirza, R. G. & Gill, M. K. Age-related macular degeneration. Med. Clin. North. Am. 105 (3), 473\u2013491. https:\/\/doi.org\/10.1016\/j.mcna.2021.01.003 (2021).","journal-title":"Med. Clin. North. Am."},{"key":"55028_CR2","doi-asserted-by":"publisher","unstructured":"Wong, W. L. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2 (2), e106\u2013e116. https:\/\/doi.org\/10.1016\/S2214-109X(13)70145-1 (2014 February).","DOI":"10.1016\/S2214-109X(13)70145-1"},{"issue":"2","key":"55028_CR3","first-page":"e144","volume":"9","author":"GBD","year":"2019","unstructured":"GBD. Blindness and vision impairment collaborators; vision loss expert group of the global burden of disease study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. Lancet Glob Health 2021 Feb. 9 (2), e144\u2013e160 (2019).","journal-title":"Lancet Glob Health 2021 Feb"},{"issue":"25","key":"55028_CR4","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth, G. A. et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J. Am. Coll. Cardiol. 76 (25), 2982\u20133021. https:\/\/doi.org\/10.1016\/j.jacc.2020.11.010 (2020).","journal-title":"J. Am. Coll. Cardiol."},{"key":"55028_CR5","doi-asserted-by":"publisher","unstructured":"Mubarik, S. et al. Population-level distribution, risk factors, and burden of mortality and disability-adjusted life years attributable to major noncommunicable diseases in Western Europe (1990\u20132021): ecological analysis. JMIR Public. Health Surveill. 17;10, e57840. https:\/\/doi.org\/10.2196\/57840 (2024 October).","DOI":"10.2196\/57840"},{"issue":"8","key":"55028_CR6","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3390\/jcm10081584","volume":"10","author":"M Chlabicz","year":"2021","unstructured":"Chlabicz, M. et al. A similar lifetime CV risk and a similar cardiometabolic profile in the moderate and high cardiovascular risk populations: a population-based study. J. Clin. Med. 10 (8), 1584. https:\/\/doi.org\/10.3390\/jcm10081584 (2021).","journal-title":"J. Clin. Med."},{"issue":"7","key":"55028_CR7","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/s0161-6420(91)32186-9","volume":"98","author":"R Klein","year":"1991","unstructured":"Klein, R. et al. The Wisconsin age-related maculopathy grading system. Ophthalmology 98 (7), 1128\u20131134. https:\/\/doi.org\/10.1016\/s0161-6420(91)32186-9 (1991).","journal-title":"Ophthalmology"},{"issue":"5","key":"55028_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/s0039-6257(05)80092-x","volume":"39","author":"AC Bird","year":"1995","unstructured":"Bird, A. C. et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv. Ophthalmol. 39 (5), 367\u2013374. https:\/\/doi.org\/10.1016\/s0039-6257(05)80092-x (1995).","journal-title":"Surv. Ophthalmol."},{"key":"55028_CR9","doi-asserted-by":"publisher","unstructured":"Budnik, A. et al. Elevated plasma levels of C1qTNF1 protein in patients with age-related macular degeneration and glucose disturbances. J. Clin. Med. 28 (15), 4391. https:\/\/doi.org\/10.3390\/jcm11154391 (2022 July).","DOI":"10.3390\/jcm11154391"},{"issue":"2","key":"55028_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0975-3583.83035","volume":"2","author":"W Zhang","year":"2011","unstructured":"Zhang, W., Liu, H., Al-Shabrawey, M., Caldwell, R. W. & Caldwell, R. B. Inflammation and diabetic retinal microvascular complications. J. Cardiovasc. Dis. Res. 2 (2), 96\u2013103. https:\/\/doi.org\/10.4103\/0975-3583.83035 (2011).","journal-title":"J. Cardiovasc. Dis. Res."},{"issue":"4","key":"55028_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1177\/2047487320908698","volume":"28","author":"K Kotseva","year":"2021","unstructured":"Kotseva, K. et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur. J. Prev. Cardiol. 28 (4), 370\u2013379. https:\/\/doi.org\/10.1177\/2047487320908698 (2021).","journal-title":"Eur. J. Prev. Cardiol."},{"issue":"6","key":"55028_CR12","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace, T. M., Levy, J. C. & Matthews, D. R. Use and abuse of HOMA modeling. Diabetes Care. 27 (6), 1487\u20131495. https:\/\/doi.org\/10.2337\/diacare.27.6.1487 (2004).","journal-title":"Diabetes Care"},{"key":"55028_CR13","unstructured":"Marmorstein, A. D., Marmorstein, L. Y., Sakaguchi, H. & Hollyfield, J. G. Spectral profiling of autofluorescence associated with lipofuscin, Bruch\u2019s Membrane, and sub-RPE deposits in normal and AMD eyes. Invest. Ophthalmol. Vis. Sci. 43 (7), 2435\u20132441 (2002 July)."},{"key":"55028_CR14","unstructured":"Nowak, J. Z. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 2006 May-June ;58(3):353\u2013363 ."},{"issue":"9","key":"55028_CR15","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00018-016-2147-8","volume":"73","author":"A Kauppinen","year":"2016","unstructured":"Kauppinen, A., Paterno, J. J., Blasiak, J., Salminen, A. & Kaarniranta, K. Inflammation and its role in age-related macular degeneration. Cell. Mol. Life Sci. 73 (9), 1765\u20131786. https:\/\/doi.org\/10.1007\/s00018-016-2147-8 (2016).","journal-title":"Cell. Mol. Life Sci."},{"key":"55028_CR16","doi-asserted-by":"publisher","unstructured":"Grisanti, S. & Tatar, O. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Prog Retin Eye Res. 27 (4), 372\u2013390. https:\/\/doi.org\/10.1016\/j.preteyeres.2008.05.002 (2008 July).","DOI":"10.1016\/j.preteyeres.2008.05.002"},{"key":"55028_CR17","doi-asserted-by":"publisher","unstructured":"Rudnicka, A. R., MacCallum, P. K., Whitelocke, R. & Meade, T. W. Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study. Eye (Lond). 24 (7), 1199\u20131206. https:\/\/doi.org\/10.1038\/eye.2010.8 (2010 July).","DOI":"10.1038\/eye.2010.8"},{"issue":"5","key":"55028_CR18","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/life11050441","volume":"11","author":"M Wici\u0144ski","year":"2021","unstructured":"Wici\u0144ski, M. et al. Evaluation of blood coagulation parameters and ADMA, NO, IL-6, and IL-18 serum levels in patients with neovascular AMD before, during, and after the initial loading phase of intravitreal aflibercept. Life (Basel). 11 (5), 441. https:\/\/doi.org\/10.3390\/life11050441 (2021).","journal-title":"Life (Basel)"},{"key":"55028_CR19","doi-asserted-by":"publisher","unstructured":"Wang, J. J. et al. The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. Ophthalmology 115 (4), 693\u2013699. https:\/\/doi.org\/10.1016\/j.ophtha.2007.05.038 (2008 April).","DOI":"10.1016\/j.ophtha.2007.05.038"},{"key":"55028_CR20","doi-asserted-by":"publisher","unstructured":"McGrath, R. T., McRae, E., Smith, O. P. & O\u2019Donnell, J. S. Platelet von Willebrand factor\u2014structure, function and biological importance. Br. J. Haematol. 148 (6), 834\u2013843. https:\/\/doi.org\/10.1111\/j.1365-2141.2009.08052.x (2010 March).","DOI":"10.1111\/j.1365-2141.2009.08052.x"},{"key":"55028_CR21","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.biochem.67.1.395","volume":"67","author":"JE Sadler","year":"1998","unstructured":"Sadler, J. E. Biochemistry and genetics of von Willebrand factor. Annu. Rev. Biochem. 67, 395\u2013424. https:\/\/doi.org\/10.1146\/annurev.biochem.67.1.395 (1998).","journal-title":"Annu. Rev. Biochem."},{"issue":"1\u20133","key":"55028_CR22","first-page":"70","volume":"107","author":"G Malukiewicz-Wi\u015bniewska","year":"2005","unstructured":"Malukiewicz-Wi\u015bniewska, G., Ro\u015b\u0107, D., Ka\u0142uzny, B. & Ka\u0142uzny, J. J. Czynnik von Willebranda w osoczu chorych ze starczym zwyrodnieniem plamki [Von Willebrand factor in plasma of patients with age related macular degeneration]. Klin. Oczna. 107 (1\u20133), 70\u201372 (2005).","journal-title":"Klin. Oczna"},{"key":"55028_CR23","doi-asserted-by":"publisher","unstructured":"Yamashita, M. et al. Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration. Sci. Rep. 24 (1), 1491. https:\/\/doi.org\/10.1038\/s41598-018-19473-0 (2018 January).","DOI":"10.1038\/s41598-018-19473-0"},{"key":"55028_CR24","doi-asserted-by":"publisher","unstructured":"Lip, P. L., Blann, A. D., Hope-Ross, M., Gibson, J. M. & Lip, G. Y. Age-related macular degeneration is associated with increased vascular endothelial growth factor, hemorheology and endothelial dysfunction. Ophthalmology 108 (4), 705\u2013710. https:\/\/doi.org\/10.1016\/s0161-6420(00)00663-1 (2001 April).","DOI":"10.1016\/s0161-6420(00)00663-1"},{"issue":"5","key":"55028_CR25","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s13238-016-0262-9","volume":"7","author":"ZQ Cao","year":"2016","unstructured":"Cao, Z. Q. & Guo, X. L. The role of galectin-4 in physiology and diseases. Protein Cell. 7 (5), 314\u2013324. https:\/\/doi.org\/10.1007\/s13238-016-0262-9 (2016).","journal-title":"Protein Cell."},{"issue":"1","key":"55028_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ejr.2022.11.009","volume":"45","author":"LA Maged","year":"2023","unstructured":"Maged, L. A., Saeed, S., Abdelfattah, W. & Gaber, W. Clinical significance of galectin-1 and galectin-4 in rheumatoid arthritis patients and their potential role as diagnostic markers. Egypt. Rheumatol. 45 (1), 99\u2013103. https:\/\/doi.org\/10.1016\/j.ejr.2022.11.009 (2023).","journal-title":"Egypt. Rheumatol."},{"key":"55028_CR27","doi-asserted-by":"publisher","unstructured":"Hokama, A., Mizoguchi, E. & Mizoguchi, A. Roles of galectins in inflammatory bowel disease. World J. Gastroenterol. 7 (33), 5133\u20135137. https:\/\/doi.org\/10.3748\/wjg.14.5133 (2008 September).","DOI":"10.3748\/wjg.14.5133"},{"key":"55028_CR28","doi-asserted-by":"publisher","unstructured":"Thijssen, V. L., Heusschen, R., Caers, J. & Griffioen, A. W. Galectin expression in cancer diagnosis and prognosis: A systematic review. Biochim. Biophys. Acta. 1855 (2), 235\u2013247. https:\/\/doi.org\/10.1016\/j.bbcan.2015.03.003 (2015 April).","DOI":"10.1016\/j.bbcan.2015.03.003"},{"key":"55028_CR29","doi-asserted-by":"publisher","unstructured":"Cabral, T. et al. Retinal and choroidal angiogenesis: a review of new targets. Int. J. Retina Vitreous. 21, 3:31. https:\/\/doi.org\/10.1186\/s40942-017-0084-9 (2017 August).","DOI":"10.1186\/s40942-017-0084-9"},{"key":"55028_CR30","doi-asserted-by":"publisher","unstructured":"Tabel, M. et al. Genetic targeting or pharmacological inhibition of galectin-3 dampens microglia reactivity and delays retinal degeneration. J. Neuroinflammation. 17 (1), 229. https:\/\/doi.org\/10.1186\/s12974-022-02589-6 (2022 September).","DOI":"10.1186\/s12974-022-02589-6"},{"key":"55028_CR31","doi-asserted-by":"publisher","unstructured":"Gardnerova, M., Blanqu\u00e9, R. & Gardner, C. R. The use of TNF family ligands and receptors and agents which modify their interaction as therapeutic agents. Curr. Drug Targets. 1 (4), 327\u2013364. https:\/\/doi.org\/10.2174\/1389450003349092 (2000 December).","DOI":"10.2174\/1389450003349092"},{"key":"55028_CR32","doi-asserted-by":"publisher","unstructured":"Tanenbaum, D. G. et al. TNFRSF10C copy number variation is associated with metastatic colorectal cancer. J. Gastrointest. Oncol. 7 (3), 306\u2013314. https:\/\/doi.org\/10.21037\/jgo.2015.11.04 (2016 June).","DOI":"10.21037\/jgo.2015.11.04"},{"key":"55028_CR33","doi-asserted-by":"publisher","unstructured":"Cai, H. H. et al. Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines. Hepatobiliary Pancreat. Dis. Int. 10 (1), 95\u2013100. https:\/\/doi.org\/10.1016\/s1499-3872(11)60014-3 (2011 February).","DOI":"10.1016\/s1499-3872(11)60014-3"},{"key":"55028_CR34","doi-asserted-by":"publisher","unstructured":"Cheng, Y. et al. Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer. Prostate 2009 Febr. 15;69(3):327\u2013335. https:\/\/doi.org\/10.1002\/pros.20882","DOI":"10.1002\/pros.20882"},{"key":"55028_CR35","doi-asserted-by":"publisher","unstructured":"Qi, Y. et al. Hypermethylation of tumor necrosis factor decoy receptor gene in non-small cell lung cancer. Oncol. Lett. 20 (1), 155\u2013164. https:\/\/doi.org\/10.3892\/ol.2020.11565 (2020 July).","DOI":"10.3892\/ol.2020.11565"},{"key":"55028_CR36","doi-asserted-by":"publisher","unstructured":"Torre-Fuentes, L. et al. Variants of genes encoding TNF receptors and ligands and proteins regulating TNF activation in familial multiple sclerosis. CNS Neurosci. Ther. 26 (11), 1178\u20131184. https:\/\/doi.org\/10.1111\/cns.13456 (2020 November).","DOI":"10.1111\/cns.13456"},{"key":"55028_CR37","doi-asserted-by":"publisher","unstructured":"Squillario, M. & Barla, A. A computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer\u2019s as a case study. BMC Med. Genomics. 5, 4:55. https:\/\/doi.org\/10.1186\/1755-8794-4-55 (2011 July).","DOI":"10.1186\/1755-8794-4-55"},{"key":"55028_CR38","doi-asserted-by":"publisher","unstructured":"Kaczynski, T. J., Husami, N. J., Au, E. D. & Farkas, M. H. Dysregulation of a lncRNA within the TNFRSF10A locus activates cell death pathways. Cell. Death Discov. 13 (1), 242. https:\/\/doi.org\/10.1038\/s41420-023-01544-5 (2023 July).","DOI":"10.1038\/s41420-023-01544-5"},{"key":"55028_CR39","doi-asserted-by":"publisher","unstructured":"Grassmann, F. et al. Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD). J. Neuroinflammation. 18 (1), 81. https:\/\/doi.org\/10.1186\/s12974-016-0548-0 (2016 April).","DOI":"10.1186\/s12974-016-0548-0"},{"key":"55028_CR40","doi-asserted-by":"publisher","unstructured":"Anand, A. et al. Does DcR1 (TNF-related apoptosis-inducing-ligand Receptor 3) have any role in human AMD pathogenesis? Sci. Rep. 18, 4:4114. https:\/\/doi.org\/10.1038\/srep04114 (2014 February).","DOI":"10.1038\/srep04114"},{"key":"55028_CR41","doi-asserted-by":"publisher","unstructured":"Mori, K. et al. TNFRSF10A downregulation induces retinal pigment epithelium degeneration during the pathogenesis of age-related macular degeneration and central serous chorioretinopathy. Hum Mol. Genet 2022 July 7;31(13):2194\u20132206. https:\/\/doi.org\/10.1093\/hmg\/ddac020","DOI":"10.1093\/hmg\/ddac020"},{"key":"55028_CR42","doi-asserted-by":"publisher","unstructured":"Sun, Y. et al. TNFRSF10A-LOC389641 rs13278062 but not REST-C4orf14-POLR2B-IGFBP7 rs1713985 was found associated with age-related macular degeneration in a Chinese population. Invest. Ophthalmol. Vis. Sci. 17 (13), 8199\u20138203. https:\/\/doi.org\/10.1167\/iovs.13-12867 (2013 December).","DOI":"10.1167\/iovs.13-12867"},{"key":"55028_CR43","doi-asserted-by":"publisher","first-page":"424019","DOI":"10.1155\/2015\/424019","volume":"2015","author":"P Perri","year":"2015","unstructured":"Perri, P. et al. TNF-related apoptosis inducing ligand in ocular cancers and ocular diabetic complications. BioMed. Res. Int. 2015, 424019. https:\/\/doi.org\/10.1155\/2015\/424019 (2015).","journal-title":"BioMed. Res. Int."},{"key":"55028_CR44","doi-asserted-by":"publisher","unstructured":"Dunaief, J. L., Dentchev, T., Ying, G. S. & Milam, A. H. The role of apoptosis in age-related macular degeneration. Arch. Ophthalmol. 120 (11), 1435\u20131442. https:\/\/doi.org\/10.1001\/archopht.120.11.1435 (2002 November).","DOI":"10.1001\/archopht.120.11.1435"},{"key":"55028_CR45","doi-asserted-by":"publisher","unstructured":"Parikh, N. et al. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types. J. Pathol. 232 (5), 522\u2013533. https:\/\/doi.org\/10.1002\/path.4321 (2014 April).","DOI":"10.1002\/path.4321"},{"key":"55028_CR46","doi-asserted-by":"publisher","unstructured":"Wiley, C. D. et al. Analysis of individual cells identifies cell-to-cell variability following induction of cellular senescence. Aging Cell. 16 (5), 1043\u20131050. https:\/\/doi.org\/10.1111\/acel.12632 (2017 October).","DOI":"10.1111\/acel.12632"},{"key":"55028_CR47","doi-asserted-by":"publisher","unstructured":"Burgaletto, C. et al. Targeting the miRNA-155\/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer\u2019s disease. Cell Death Dis 2021 October 5;12(10):905. https:\/\/doi.org\/10.1038\/s41419-021-04165-x","DOI":"10.1038\/s41419-021-04165-x"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55028-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55028-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55028-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T23:25:20Z","timestamp":1788477920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55028-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55028"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55028-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"17 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","label":"Patient consent statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee on Medical University of Bialystok (approval number: R-I-002\/108\/2016).","order":3,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"27752"}}